TY - JOUR
T1 - Hypereosinophilic syndrome presenting with gastrointestinal manifestations
AU - Hinkle, Louis
AU - Gandhi, Nisarg
AU - Neal, Ryan
AU - Narcisse, Victor
N1 - Publisher Copyright:
© 2023 BMJ Publishing Group Limited. Published by BMJ.
PY - 2023/4/4
Y1 - 2023/4/4
N2 - Hypereosinophilic syndrome (HES) is a spectrum of diseases characterised by an elevated eosinophilic count causing end-organ damage. Differential diagnoses of hypereosinophilia are vast and include drug hypersensitivities, allergies, infections, cancers, autoimmune disorders and rare eosinophilic syndromes. Herein, we describe a case of a patient presenting with gastrointestinal (GI) symptoms including progressive dysphagia, abdominal distension, vomiting, diarrhoea and abdominal pain with significant peripheral eosinophilia who was found to have an overlap HES involving the GI tract. This patient's eosinophilia was rapidly corrected with intravenous methylprednisolone, and the patient experienced gradual resolution of clinical symptoms with maintenance oral prednisone. Due to the rarity and diverse presentation of HES, there are few large, longitudinal studies that describe disease progression and inform treatment guidelines. This case demonstrates the difficulty in designing a treatment regimen for these patients and emphasises the clinical need for improved understanding of HES.
AB - Hypereosinophilic syndrome (HES) is a spectrum of diseases characterised by an elevated eosinophilic count causing end-organ damage. Differential diagnoses of hypereosinophilia are vast and include drug hypersensitivities, allergies, infections, cancers, autoimmune disorders and rare eosinophilic syndromes. Herein, we describe a case of a patient presenting with gastrointestinal (GI) symptoms including progressive dysphagia, abdominal distension, vomiting, diarrhoea and abdominal pain with significant peripheral eosinophilia who was found to have an overlap HES involving the GI tract. This patient's eosinophilia was rapidly corrected with intravenous methylprednisolone, and the patient experienced gradual resolution of clinical symptoms with maintenance oral prednisone. Due to the rarity and diverse presentation of HES, there are few large, longitudinal studies that describe disease progression and inform treatment guidelines. This case demonstrates the difficulty in designing a treatment regimen for these patients and emphasises the clinical need for improved understanding of HES.
KW - Endoscopy
KW - Haematology (incl blood transfusion)
KW - Stomach and duodenum
UR - http://www.scopus.com/inward/record.url?scp=85151785332&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151785332&partnerID=8YFLogxK
U2 - 10.1136/bcr-2022-254388
DO - 10.1136/bcr-2022-254388
M3 - Article
C2 - 37015765
AN - SCOPUS:85151785332
VL - 16
JO - BMJ Case Reports
JF - BMJ Case Reports
SN - 1757-790X
IS - 4
M1 - e254388
ER -